Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 48
- Opinion
Uncertainty Kills: Inside the Cannabis Industry’s Battle with Trump’s Trade War
The shock announcement this week that a federal trade court had ruled that key elements of President Trump’s flagship tariff policy were unconstitutional has come as a major relief for any internationally-facing US business, not least the cannabis sector.
- Uncategorized
Cannabis Debt Crisis Intensifies as Lenders Circle Overleveraged Operators
As spurred lenders begin to encircle cannabis companies owing an estimated $3 billion in collective debt coming due soon, one overleveraged operator is resorting to what observers say are increasingly creative and desperate methods to protect assets from liquidation.
- Uncategorized
Deutschlands grüner Rausch: Medizinische Cannabisimporte setzen Rekordwachstum fort, während der politische Widerstand wächst
Die deutschen Importe von medizinischem Cannabis haben ihren kometenhaften Aufstieg nach der Verabschiedung des Cannabisgesetzes (CanG) fortgesetzt und sind im ersten Quartal 2025 gegenüber dem vierten Quartal 2024 um weitere 15% auf insgesamt 37.223 kg gestiegen.
- Data & Analysis
Germany’s Green Rush: Medical Cannabis Imports Continue Record Growth, As Political Pushback Grows in Tandem
German medical cannabis imports have continued their meteoric rise in the wake of the passage of its Cannabis Act (CanG), rising a further 15% on Q4, 2024 in the first quarter of 2025, totalling 37,223 kg.
- Adult-Use
Landmark UK Report Recommends Decriminalising Cannabis Possession, Banning Stop & Search, & Cannabis Training for Police
Cannabis possession for personal use should ‘no longer be a criminal offence’, recommends a highly anticipated report led by Lord Charlie Falconer QC.
- Your #1 Podcast on Cannabis News
Business of Cannabis: Podcast | The Broken Promise of UK Medical Cannabis – Releaf x Fieldfisher
The third in our series of guest episodes features a discussion between the CEO of Releaf, Tim Kirby, and Robert Jappie, a partner at Fieldfisher LLP specialising in regulatory law.
- Uncategorized
Portuguese Police Bust Criminal Gang Operating As Medical Cannabis Cultivators
Portuguese cultivators have welcomed moves by the country’s police to crack down on a criminal gang using loopholes in its medical cannabis laws to cultivate and illegally export around £15m of product.
- Companies
Pharmaceutical Cannabis Steps Into the Spotlight as DanCann, Phytanix and Sandoz Unveil Major Moves
Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector.
- Uncategorized
Precision Over Potency: Personalised Cannabis Medicine is Coming of Age
One of the key differences between medical cannabis and other more traditional treatments is the highly personalised nature of how each patient is affected.
- Adult-Use
Smell That? Malta’s New Cannabis Crackdown Could Cost You €235
Malta’s government has passed a string of controversial new regulations imposing stricter controls on cannabis users and associations, causing uproar from proponents.
- Uncategorized
Was kann das Vereinigte Königreich von Deutschlands boomendem Markt für medizinisches Cannabis lernen?
Da Deutschland vor kurzem einige grundlegende Änderungen an seinem Rahmenwerk für medizinisches Cannabis vorgenommen hat, die dazu beigetragen haben, den Zugang erheblich zu erweitern und die Patientenzahlen in die Höhe zu treiben, haben wir mit der führenden britischen Klinik Releaf gesprochen, um zu erfahren, welche strukturellen, kulturellen und klinischen Lehren das Vereinigte Königreich aus dem deutschen Erfolg ziehen kann.
- Uncategorized
What Can the UK Learn From Germany’s Booming Medical Cannabis Market?
With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success.
